HKU Scholars Hub: Browsing DSpace

Browsing "Li Ka Shing Faculty of Medicine" by Author thompson, a

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 24 next >

Title	Author(s)	Issue Date
A global scientific strategy to cure hepatitis B Journal:The Lancet Gastroenterology & Hepatology	Revill, PA Chisari, FV Block, JM Dandr, M Gehring, AJ Guo, H Hu, J Kramvis, A Lampertico, P Janssen, HLA Levrero, M Li, W Liang, TJ Lim, SG Lu, F Penicaud, MC Tavis, JE Thimme, R Arbuthnot, P Boonstra, A Chang, KM Chen, PJ Glebe, D Guidotti, LG Fellay, J Ferrari, C Jansen, L Lau, DTY Lok, AS Maini, MK Mason, W Matthews, G Paraskevis, D Peterse, J Rehermann, B Shin, EC Thompson, A van Bömmel, F Wang, FS Watashi, K Yang, HC Yuan, Z Yuen, MF Block, T Miller, V Protzer, U Bréchot, C Locarnini, S Peters, MG Schinazi, RF Zoulim, F	2019
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV Journal:PLoS One	Pan, CQ Chang, TT Bae, SH Brunetto, M Seto, WK Coffin, CS Tan, SK Mo, S Flaherty, JF Gaggar, A Nguyen, MH Celen, MK Thompson, A Gane, EJ Bulterys, M	2021
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes Journal:Schizophrenia Research	Youn, S Phillips, LJ Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Mallawaarachchi, SR Amminger, GP Farhall, J Bolt, LK Nelson, B Yuen, HP McGorry, PD Markulev, C Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2020
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP Meyer, BJ	2020
Distress related to attenuated psychotic symptoms: Static and dynamic association with transition to psychosis, non-remission and transdiagnostic symptomatology in clinical high-risk patients in an international intervention trial Journal:Schizophrenia Bulletin Open	Nelson, B Yuen, HP Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfe, MR Schlögelhofer, M Smesny, S Tedja, A Thompson, A Verma, S Yung, AR McGorry, PD	2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk? Journal:Schizophrenia Research	Hadar, H Zhang, H Phillips, LJ Amminger, GP Berger, GE Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020
Dose response with the RNA interference (RNAi) therapy JNJ-3989 combined with nucleos(t)ide analogue (NA) treatment in expanded cohorts of patients (pts) with chronic hepatitis B (CHB) Proceeding/Conference:Hepatology	Gane, EJ Locarnini, S Lim, TH Strasser, SI Sievert, W Cheng, W Thompson, A Given, BD Schluep, T Hamilton, J Biermer, M Kalmeijer, R Beumont-Mauviel, M Lenz, O Cloherty, G Wong, DKH Schwabe, C Jackson, K Ferrari, C Lai, CL Gish, RG Yuen, RMF	2019
First results with RNA interference (RNAi) in chronic hepatitis b (CHB) using ARO-HBV Proceeding/Conference:Hepatology	Gane, EJ Locarnini, S Lim, TH Strasser, S Sievert, W Cheng, W Thompson, A Given, B Schluep, T Hamilton, J Li, Z Cloherty, G Wong, DKH Schwabe, C Jackson, K Ferrari, C Lai, CL Gish, RG Yuen, RMF	2018
Greater sequence diversity during early hepatitis B virus decline on vebicorvir plus entecavir is associated with a lower level of virus rebound following switch to entecavir monotherapy. Poster Presentation (THU346) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Li, L Revill, P Yan, R Chan, C Tian, H Ma, J Stamm, LM Yuen, RMF Thompson, A Kitrinos, KM	2022
IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Bourgeois, S Lim, Y-S Gane, EJ Lee, HW Cheng, W Heo, J Kim, W Buti, M Thompson, A Matthews, G Janczewska, E Ryder, S Andrade, RJ Yuan, Y Benlahrech, A Wustner, J Dorrell, L Yuen, RMF	2022
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Bolt, LK Amminger, GP Farhall, J McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2019
No emergent core inhibitor resistance in patients with chronic hepatitis B virus infection treated with Vebicorvir in combination with a nucleos (t)ide reverse transcriptase inhibitor. (Poster presentation: PO-1286) Proceeding/Conference:Journal of Hepatology	Yuen, RMF Locarnini, S Revill, P Yan, R Ouyang, L Cai, D Delaney, W Kitrinos, K Thompson, A Zoulim, F Sulkowski, M	2021
Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis Journal:Early Intervention in Psychiatry	McLaverty, A Allott, KA Berger, M Hester, R McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher‐Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP	2020
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis Journal:Psychotherapy and Psychosomatics	Hartmann, JA McGorry, P Schmidt, S Amminger, P Yuen, HP Markuley, C Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S McHugh, MJ Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yung, A Nelson, B	2017
Protein arginine-methyltransferase-dependent oncogenesis Journal:Nature Cell Biology	Cheung, N Chan, LC Thompson, A Cleary, ML So, CWE	2007
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial Journal:Frontiers in Psychiatry	Berger, M Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Mitchell, TW Meyer, BJ Thompson, A Yung, AR McGorry, PD Amminger, GP	2019
Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors Proceeding/Conference:Journal of Hepatology	Gane, E Locarnini, S Lim, TH Strasser, S Sievert, W Cheng, W Thompson, A Given, B Schluep, T Hamilton, J Biermer, M Kalmeijer, R Beumont-Mauviel, M Lenz, O De Ridder, F Cloherty, G Wong, DKH Schwabe, C Jackson, K Ferrari, C Lai, CL Gish, RG Yuen, RMF	2021
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold Proceeding/Conference:Journal of Hepatology	Yuen, RMF Locarnini, S Lim, TH Strasser, S Sievert, W Cheng, W Thompson, A Given, B Schluep, T Hamilton, J Cloherty, G Wong, DKH Schwabe, C Jackson, K Ferrari, C Lai, CL Gish, RG Gane, E	2019
Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen suppression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment Proceeding/Conference:Journal of Hepatology	Gane, E Locarnini, S Lim, TH Strasser, S Sievert, W Cheng, W Thompson, A Given, B Schluep, T Hamilton, J Biermer, M Kalmeijer, R Beumont-Mauviel, M Lenz, O Cloherty, G Wong, DKH Schwabe, C Jackson, K Ferrari, C Lai, CL Gish, RG Yuen, RMF	2020

Showing results 1 to 20 of 24 next >